Bradley Foster & Sargent’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.36M Sell
116,274
-22,348
-16% -$2.1M 0.12% 128
2026
Q1
$16.4M Sell
138,622
-21,222
-13% -$2.62M 0.25% 83
2025
Q4
$20.1M Sell
159,844
-15,433
-9% -$2.01M 0.3% 71
2025
Q3
$25.6M Sell
175,277
-30,390
-15% -$4.59M 0.38% 60
2025
Q2
$32.1M Sell
205,667
-1,464
-0.7% -$232K 0.5% 54
2025
Q1
$34.1M Sell
207,131
-9,498
-4% -$1.58M 0.58% 47
2024
Q4
$35.3M Buy
216,629
+19,889
+10% +$3.56M 0.59% 47
2024
Q3
$38.4M Buy
196,740
+1,113
+0.6% +$205K 0.64% 46
2024
Q2
$33.9M Sell
195,627
-43,927
-18% -$7.31M 0.61% 46
2024
Q1
$40.5M Buy
239,554
+31,328
+15% +$5.87M 0.73% 41
2023
Q4
$41.1M Sell
208,226
-3,179
-2% -$563K 0.8% 39
2023
Q3
$36.4M Hold
211,405
0.77% 39
2023
Q2
$36.4M Sell
211,405
-3,239
-2% -$560K 0.77% 39
2023
Q1
$35.7M Sell
214,644
-2,494
-1% -$409K 0.85% 40
2022
Q4
$31.8M Sell
217,138
-2,099
-1% -$311K 0.8% 41
2022
Q3
$32.5M Sell
219,237
-526
-0.2% -$87.9K 0.9% 34
2022
Q2
$37.8M Sell
219,763
-930
-0.4% -$161K 0.97% 32
2022
Q1
$41.6M Sell
220,693
-7,353
-3% -$1.45M 0.89% 34
2021
Q4
$55.6M Sell
228,046
-2,960
-1% -$648K 1.15% 21
2021
Q3
$44.8M Sell
231,006
-8,049
-3% -$1.62M 1.05% 27
2021
Q2
$44.5M Sell
239,055
-5,541
-2% -$962K 1.04% 27
2021
Q1
$38.5M Buy
244,596
+6,843
+3% +$1.08M 0.98% 30
2020
Q4
$39.3M Buy
237,753
+46
+0% +$7.48K 1.04% 27
2020
Q3
$39.3M Buy
+237,707
New +$36.5M 1.15% 25
2020
Q1
$29M Sell
246,203
-1,653
-0.7% -$218K 1.16% 23
2019
Q4
$32.8M Buy
247,856
+2,905
+1% +$361K 1.01% 29
2019
Q3
$30.5M Sell
244,951
-8,679
-3% -$1.05M 1.02% 32
2019
Q2
$28.8M Sell
253,630
-2,081
-0.8% -$218K 0.95% 34
2019
Q1
$25.7M Sell
255,711
-9,220
-3% -$837K 0.9% 37
2018
Q4
$22.7M Sell
264,931
-13,564
-5% -$1.22M 0.91% 35
2018
Q3
$25.5M Sell
278,495
-6,836
-2% -$606K 0.87% 38
2018
Q2
$24.3M Buy
285,331
+11,328
+4% +$956K 0.87% 39
2018
Q1
$22.9M Sell
274,003
-17,433
-6% -$1.37M 0.87% 39
2017
Q4
$21M Sell
291,436
-2,255
-0.8% -$155K 0.76% 45
2017
Q3
$18.7M Sell
293,691
-3,145
-1% -$197K 0.71% 50
2017
Q2
$18.5M Sell
296,836
-1,379
-0.5% -$81.4K 0.74% 44
2017
Q1
$15.9M Buy
298,215
+1,408
+0.5% +$76.1K 0.64% 54
2016
Q4
$15.9M Buy
296,807
+105
+0% +$5.34K 0.67% 57
2016
Q3
$15.4M Buy
296,702
+673
+0.2% +$34.1K 0.68% 54
2016
Q2
$14.1M Sell
296,029
-5,208
-2% -$246K 0.63% 57
2016
Q1
$13.4M Buy
301,237
+18,636
+7% +$791K 0.62% 54
2015
Q4
$13.5M Sell
282,601
-499
-0.2% -$22.6K 0.62% 56
2015
Q3
$11.7M Buy
283,100
+13,081
+5% +$607K 0.57% 60
2015
Q2
$13M Buy
270,019
+11,267
+4% +$538K 0.59% 59
2015
Q1
$12M Buy
258,752
+11,500
+5% +$518K 0.55% 66
2014
Q4
$10.6M Buy
247,252
+25,050
+11% +$1.02M 0.5% 72
2014
Q3
$8.21M Buy
222,202
+375
+0.2% +$12.8K 0.39% 82
2014
Q2
$7.16M Sell
221,827
-11,190
-5% -$343K 0.35% 86
2014
Q1
$6.74M Buy
233,017
+10,125
+5% +$309K 0.35% 84
2013
Q4
$7.29M Buy
222,892
+6,422
+3% +$205K 0.39% 77
2013
Q3
$6.74M Buy
216,470
+148,627
+219% +$4.55M 0.39% 76
2013
Q2
$2.1M Buy
+67,843
New +$2.2M 0.13% 124

Other funds holding ZTS

Bradley Foster & Sargent's ZTS Position: Q2 2026 in Review

Bradley Foster & Sargent reduced its Zoetis (ZTS) stake by 16% in Q2 2026, selling an estimated $2.1M and leaving 116,274 shares worth $8.36M. The position accounts for 0.12% of the portfolio, ranked #128.

Bradley Foster & Sargent first reported a position in ZTS in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.6M in Q4 2021. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Bradley Foster & Sargent held 116,274 shares of Zoetis worth $8.36M as of Q2 2026.
  • Bradley Foster & Sargent sold 22,348 Zoetis shares in Q2 2026, an estimated $2.1M.
  • Zoetis made up 0.12% of Bradley Foster & Sargent's portfolio in Q2 2026, its #128 holding.
  • Bradley Foster & Sargent first reported a position in Zoetis in Q2 2013 and has held it in 52 quarters since.
  • Bradley Foster & Sargent's Zoetis position peaked at $55.6M in Q4 2021.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.